RPID - NASDAQ
Rapid Micro Biosystems, Inc.
$2.00
+1.8%Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
At a Glance
Live Snapshotrpid
Net Cash Provided by Financing Activities
Last Annual Value
19.77M
3-Year CAGR
206%
5-Year CAGR
-21%
10-Year CAGR
3%
Rapid Micro Biosystems, Inc. Competitors Analysis of Net Cash Provided by Financing Activities
| Company | Net Cash Provided by Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Rapid Micro Biosystems, Inc. NASDAQ:RPID | 19.77M | 410.1% | -38.1% | N/A | |
 Vivani Medical, Inc. NASDAQ:VANI | 23.27M | 459.3% | 14.9% | 1.3% | |
 Sera Prognostics, Inc. NASDAQ:SERA | 54.03M | 315.7% | -19.5% | N/A | |
 Owlet, Inc. NYSE:OWLT | 32.10M | 3.5% | -23.3% | N/A | |
 LENSAR, Inc. NASDAQ:LNSR | 10.26M | -19.6% | 95.3% | N/A | |
 MaxCyte, Inc. NASDAQ:MXCT | 656.00K | -32.6% | -69.1% | -25.1% | |
 Sight Sciences, Inc. NASDAQ:SGHT | 1.79M | 17.5% | -62.8% | N/A | |
 TriSalus Life Sciences, Inc. NASDAQ:TLSI | 30.76M | -17.4% | -9.5% | N/A | |
 Hyperfine, Inc. NASDAQ:HYPR | 27.50M | 440.7% | -31.1% | N/A | |
 AVITA Medical, Inc. NASDAQ:RCEL | 14.94M | -28.2% | -25.3% | N/A | |
 Apyx Medical Corporation NASDAQ:APYX | 9.58M | -33.2% | 231.3% | 5.2% |
Rapid Micro Biosystems, Inc. Fair Value Envelope
Related Guides
Continue your RPID research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.